Filing Details
- Accession Number:
- 0000014272-21-000130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-07 13:00:00
- Reporting Period:
- 2021-05-05
- Accepted Time:
- 2021-05-07 16:57:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1744507 | Adam Dubow | Bristol-Myers Squibb Company 430 E. 29Th Street, 14 Floor New York NY 10016 | Svp,Chiefcompliance&Ethicsoff. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2021-05-05 | 3,119 | $64.21 | 16,243 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.10 Par Value | 965 | Indirect | By BMY Savings and Investment Program |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in two transactions at prices $64.21 and $64.215, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on a plan statement as of the end of the most recent fiscal quarter.